Elizabeth A. Harrington

Publications

• Proliferation Tumour Marker Network (PTM-NET) for the Identification of Tumour Region in Ki67 Stained Breast Cancer Whole Slide Images
  Scientific Reports. 09, 2019  |   Pubmed ID: 31492872
• Optimisation of Robust Singleplex and Multiplex Droplet Digital PCR Assays for High Confidence Mutation Detection in Circulating Tumour DNA
  Scientific Reports. 09, 2019  |   Pubmed ID: 31477768
• A Phase II Study to Assess the Safety and Efficacy of the Dual MTORC1/2 Inhibitor Vistusertib in Relapsed, Refractory DLBCL
  Hematological Oncology. Oct, 2019  |   Pubmed ID: 31385336
• Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial
  Cancer Discovery. 10, 2019  |   Pubmed ID: 31315834
• PRAD50: a Novel and Clinically Applicable Pharmacodynamic Biomarker of Both ATM and ATR Inhibition Identified Using Mass Spectrometry and Immunohistochemistry
  British Journal of Cancer. 11, 2018  |   Pubmed ID: 30385821
• Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 12, 2018  |   Pubmed ID: 30082476
• Functional Significance of Co-occurring Mutations in and in Breast Cancer
  Oncotarget. Apr, 2018  |   Pubmed ID: 29765551
• Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2017  |   Pubmed ID: 27733477
• Nucleic Acid Extraction from Formalin-fixed Paraffin-embedded Cancer Cell Line Samples: a Trade off Between Quantity and Quality?
  BMC Clinical Pathology. 2016  |   Pubmed ID: 28649177
• Characterization of FGFR1 Locus in SqNSCLC Reveals a Broad and Heterogeneous Amplicon
  PloS One. 2016  |   Pubmed ID: 26905262
• Evaluating Robustness and Sensitivity of the NanoString Technologies NCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples
  Cancer Research. Jul, 2015  |   Pubmed ID: 26069246
• First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual M-TORC 1/2 Inhibitor AZD2014
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2015  |   Pubmed ID: 25805799
• Inhibition of PI3Kβ Signaling with AZD8186 Inhibits Growth of PTEN-deficient Breast and Prostate Tumors Alone and in Combination with Docetaxel
  Molecular Cancer Therapeutics. Jan, 2015  |   Pubmed ID: 25398829
• Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString NCounter System
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2015  |   Pubmed ID: 25301847